Journal of International Oncology››2019,Vol. 46››Issue (6): 321-326.doi:10.3760/cma.j.issn.1673-422X.2019.06.001
Yu Kun, Wang Weiya, Cai Xinyi, Cheng Xianshuo, Zhao Xiaofeng, Bie Yaqin, Li Qiang
Online:
2019-06-08Published:
2019-07-11Contact:
Li Qiang, Email: 1390811139@qq.com E-mail:1390811139@qq.comSupported by:
Science and Technology Project of Yunnan Province of China [2017FE467(072)]; Health Science and Technology Project of Yunnan Province of China (2016NS101)
Yu Kun, Wang Weiya, Cai Xinyi, Cheng Xianshuo, Zhao Xiaofeng, Bie Yaqin, Li Qiang. Effects of microRNA-424-5p on proliferation, migration and invasion of colorectal cancer cells by regulating OTX1[J]. Journal of International Oncology, 2019, 46(6): 321-326.
[1] Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6): 394-424. DOI: 10.3322/caac.21492. [2] Wang F, Wang J, Yang X, et al. MiR-424-5p participates in esophageal squamous cell carcinoma invasion and metastasis via SMAD7 pathway mediated EMT[J]. Diagn Pathol, 2016, 11(1): 88. DOI: 10.1186/s13000-016-0536-9. [3] Zhang M, Zeng J, Zhao Z, et al. Loss of miR-424-3p, not miR-424-5p, confers chemoresistance through targeting YAP1 in nonsmall cell lung cancer[J]. Mol Carcinog, 2017, 56(3): 821-832. DOI: 10.1002/mc.22536. [4] Pantò MR, Zappalà A, Tuorto F, et al. Role of the Otx1 gene in cell differentiation of mammalian cortex[J]. Eur J Neurosci, 2004, 19(10): 2893-2902. DOI: 10.1111/j.0953-816X.2004.03326.x. [5] de Haas T, Oussoren E, Grajkowska W, et al. OTX1 and OTX2 expression correlates with the clinicopathologic classification of medulloblastomas[J]. J Neuropathol Exp Neurol, 2006, 65(2): 176-186. DOI: 10.1097/01.jnen.0000199576.70923.8a. [6] Terrinoni A, Pagani IS, Zucchi I, et al. OTX1 expression in breast cancer is regulated by p53[J]. Oncogene, 2011, 30(27): 3096-3103. DOI: 10.1038/onc.2011.31. [7] Yu K, Cai XY, Li Q, et al. OTX1 promotes colorectal cancer progression through epithelialmesenchymal transition[J]. Biochem Biophys Res Commun, 2014, 444(1): 1-5. DOI: 10.1016/j.bbrc.2013.12.125. [8] Harrandah AM, Mora RA, Chan EKL. Emerging microRNAs in cancer diagnosis, progression, and immune surveillance[J]. Cancer Lett, 2018, 438: 126-132. DOI: 10.1016/j.canlet.2018.09.019. [9] Zhang Y, Li T, Guo P, et al. MiR-4245p reversed epithelialmesenchymal transition of anchorageindependent HCC cells by directly targeting ICAT and suppressed HCC progression[J]. Sci Rep, 2014, 4: 6248. DOI: 10.1038/srep06248. [10] Wu CT, Lin WY, Chang YH, et al. DNMT1-dependent suppression of microRNA424 regulates tumor progression in human bladder cancer[J]. Oncotarget, 2015, 6(27): 24119-24131. DOI: 10.18632/oncotarget.4431. [11] Jepsen RK, Novotny GW, Klarskov LL, et al. Intratumor heterogeneity of microRNA-92a, microRNA-375 and microRNA-424 in colorectal cancer[J]. Exp Mol Pathol, 2016, 100(1): 125-131. DOI: 10.1016/j.yexmp.2015.12.004. [12] Yang H, Zheng W, Shuai X, et al. MicroRNA424 inhibits Akt3/E2F3 axis and tumor growth in hepatocellular carcinoma[J]. Oncotarget, 2015, 6(29): 27736-27750. DOI: 10.18632/oncotarget.4811. [13] Chen B, Duan L, Yin G, et al. Simultaneously expressed miR424 and miR381 synergistically suppress the proliferation and survival of renal cancer cells—Cdc2 activity is upregulated by targeting WEE1[J]. Clinics (Sao Paulo), 2013, 68(6): 825-833. DOI: 10.6061/clinics/2013(06)17. [14] Peng HY, Jiang SS, Hsiao JR, et al. IL-8 induces miR-424-5p expression and modulates SOCS2/STAT5 signaling pathway in oral squamous cell carcinoma [J]. Mol Oncol, 2016, 10(6): 895-909. DOI: 10.1016/j.molonc.2016.03.001. [15] Wei S, Li Q, Li Z, et al. miR4245p promotes proliferation of gastric cancer by targeting Smad3 through TGF-β signaling pathway[J]. Oncotarget, 2016, 7(46): 75185-75196. DOI: 10.18632/oncotarget.12092. [16] Long XH, Mao JH, Peng AF, et al. Tumor suppressive microRNA-424 inhibits osteosarcoma cell migration and invasion via targeting fatty acid synthase[J]. Exp Ther Med, 2013, 5(4): 1048-1052. DOI: 10.3892/etm.2013.959. [17] Zhang D, Shi Z, Li M, et al. Hypoxiainduced miR-424 decreases tumor sensitivity to chemotherapy by inhibiting apoptosis[J]. Cell Death Dis, 2014, 5: e1301. DOI: 10.1038/cddis.2014.240. [18] Qin SC, Zhao Z, Sheng JX, et al. Dowregulation of OTX1 attenuates gastric cancer cell proliferation, migration and invasion[J]. Oncol Rep, 2018, 40(4): 1907-1916. DOI: 10.3892/or.2018.6596. |
[1] | Zhang Rui, Chu Yanliu.Research progress of colorectal cancer risk assessment models based on FIT and gut microbiota[J]. Journal of International Oncology, 2024, 51(6): 370-375. |
[2] | Gao Fan, Wang Ping, Du Chao, Chu Yanliu.Research progress on intestinal flora and non-surgical treatment of the colorectal cancer[J]. Journal of International Oncology, 2024, 51(6): 376-381. |
[3] | Wang Junyi, Hong Kaibin, Ji Rongjia, Chen Dachao.Effect of cancer nodules on liver metastases after radical resection of colorectal cancer[J]. Journal of International Oncology, 2024, 51(5): 280-285. |
[4] | Ren Lu, Xie Xiaoli, Zhang Kun, Wang Lijuan.Effects and mechanisms of dihydroartemisinin combined with carfilzomib on the activity, proliferation, and apoptosis of multiple myeloma cells[J]. Journal of International Oncology, 2024, 51(3): 129-136. |
[5] | Gong Yan, Chen Honglei.Research progress on the mechanism of microRNA regulation of cisplatin resistance in ovarian cancer[J]. Journal of International Oncology, 2024, 51(3): 186-190. |
[6] | Sun Guobao, Yang Qian, Zhuang Qingchun, Gao Binbin, Sun Xiaogang, Song Wei, Sha Dan.Research progress on the histopathological growth patterns of colorectal liver metastasis[J]. Journal of International Oncology, 2024, 51(2): 114-118. |
[7] | Xiang Yuling, Tan Jiajie, Xiong Yuanguo, Zhao Lirong, Li Chen, Zhang Hong.Effects of Anhydroicaritin on the proliferation, migration and apoptosis of hepatocellular carcinoma cells[J]. Journal of International Oncology, 2023, 50(9): 513-519. |
[8] | Liu Debao, Sun Ziwen, Lu Shoutang, Xu Haidong.Expression and clinical significance of ASB6 in colorectal cancer tissues[J]. Journal of International Oncology, 2023, 50(8): 470-474. |
[9] | Chen Zhuo, Tao Jun, Chen Lin, Ke Jing.Value of detection of peripheral blood miR-194 combined with fecal miR-143 in the clinical screening of colorectal cancer[J]. Journal of International Oncology, 2023, 50(5): 268-273. |
[10] | Quan Zhenhao, Xu Feipeng, Huang Zhe, Huang Xianjin, Chen Rihong, Sun Kaiyu, Hu Xu, Lin Lin.lncRNA FTX silencing inhibits gastric cancer cell proliferation through the miR-22-3p/NLRP3 inflammasome pathway[J]. Journal of International Oncology, 2023, 50(4): 202-207. |
[11] | Huang Zhen, Zhang Caiyutian, Ke Shaobo, Shi Wei, Zhao Wensi, Chen Yongshun.Construction of postoperative prognosis model for patients with colorectal cancer[J]. Journal of International Oncology, 2023, 50(3): 157-163. |
[12] | Xu Liangfu, Li Yuanfei.Research progress on tumor microenvironment and immune combination therapy of MSS colorectal cancer[J]. Journal of International Oncology, 2023, 50(3): 186-190. |
[13] | Liu Yujie, Zhao Zhiqiang, Wang Zicheng.Levels and diagnostic value of TOP2A and ERBB2 in peripheral blood mononuclear cells of patients with early colorectal cancer[J]. Journal of International Oncology, 2023, 50(12): 717-722. |
[14] | Tao Hong, Yin Hong, Luo Hong, Tao Jiayu.Potential strategies for targeting tumor-associated macrophages to enhance the efficacy of immune checkpoint inhibitors for colorectal cancer[J]. Journal of International Oncology, 2023, 50(11): 683-687. |
[15] | Wang Xi, Wu Chuanqing.Research progress in reversing multidrug resistance in colorectal cancer[J]. Journal of International Oncology, 2023, 50(1): 42-46. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||